# FDA Inspection 1287422 - Neutripure Corporation - October 17, 2025

Source: https://www.keypedia.com/records/fda_inspections/neutripure-corporation/098808a2-aa95-4fd2-af9e-b86636bdd2a0
Source feed: FDA_Inspections

> FDA inspection 1287422 of Neutripure Corporation, October 17, 2025. Classification: Official Action Indicated (OAI). 5 citations under 21 CFR part 211. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1287422
- Company Name: Neutripure Corporation
- Inspection Date: 2025-10-17
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Minneapolis District Office
- Citation Count: 5

## Related Officers

- [Investigator](https://www.keypedia.com/people/beatrix-d-hippe/4a5a5258-3099-46cd-9e56-2dce60668ac5)
- [Issuing Officer](https://www.keypedia.com/people/elizabeth-r-bloom/51c7ec4e-97bb-4543-adc3-cf02d335f159)

Company: https://www.keypedia.com/companies/neutripure-corporation/58728ca9-7a01-420c-a3d7-05ccbbb206e3

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d